Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy-Reference-Cited by-同舟云学术

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy

Published:2013-12 Issue:6 Volume:15 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Díaz Flaqué María C,Galigniana Natalia M,Béguelin Wendy,Vicario Rocío,Proietti Cecilia J,Russo Rosalía Cordo,Rivas Martín A,Tkach Mercedes,Guzmán Pablo,Roa Juan C,Maronna Esteban,Pineda Viviana,Muñoz Sergio,Mercogliano María Florencia,Charreau Eduardo H,Yankilevich Patricio,Schillaci Roxana,Elizalde Patricia V

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3587.pdf

Reference79 articles.

1. Daniel AR, Hagan CR, Lange CA: Progesterone receptor action: defining a role in breast cancer. Expert Rev Endocrinol Metab. 2011, 6: 359-369. 10.1586/eem.11.25.

2. Balana ME, Lupu R, Labriola L, Charreau EH, Elizalde PV: Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Oncogene. 1999, 18: 6370-6379. 10.1038/sj.onc.1203028.

3. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F: Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 1998, 17: 2008-2018. 10.1093/emboj/17.7.2008.

4. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP: Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell. 2001, 8: 269-280. 10.1016/S1097-2765(01)00304-5.

5. Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, Boonyaratanakornkit V, Charreau EH, Bal de Kier JE, Schillaci R, Elizalde PV: Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol. 2007, 21: 1335-1358. 10.1210/me.2006-0304.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells;The Journal of Steroid Biochemistry and Molecular Biology;2024-03

2. Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy;Breast Cancer Research;2023-11-02

3. TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma;Cell Death Discovery;2023-06-21

4. Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer;Cell Death & Disease;2022-05-09

5. The regulation of cyclin D promoters – review;Cancer Treatment and Research Communications;2021